-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $38

Benzinga·03/25/2026 15:25:29
Listen to the news
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price target from $62 to $38.